Technical Analysis for CLIN - Clinigen Group Plc

Grade Last Price % Change Price Change
grade C 987.5 0.15% 1.50
CLIN closed up 0.15 percent on Monday, January 20, 2020, on 69 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CLIN trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength 0.15%
Above Upper BB Strength 0.15%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.
Articles Biotechnology Health Pharmaceutical Pharmaceutical Industry Clinical Trial Pharmaceutical Products Pharmaceutical Industry In China Pharmaceuticals Policy Clinical Research Medication Design Of Experiments Product Testing

Is CLIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1069.0
52 Week Low 718.5
Average Volume 200,583
200-Day Moving Average 928.07
50-Day Moving Average 890.83
20-Day Moving Average 933.10
10-Day Moving Average 940.00
Average True Range 25.18
ADX 20.4
+DI 27.00
-DI 11.73
Chandelier Exit (Long, 3 ATRs ) 918.46
Chandelier Exit (Short, 3 ATRs ) 960.04
Upper Bollinger Band 981.78
Lower Bollinger Band 884.42
Percent B (%b) 1.06
BandWidth 10.43
MACD Line 23.18
MACD Signal Line 17.52
MACD Histogram 5.6628
Fundamentals Value
Market Cap 907.79 Million
Num Shares 919 Thousand
EPS 6.30
Price-to-Earnings (P/E) Ratio 156.75
Price-to-Sales 349.05
Price-to-Book 314.47
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1010.75
Resistance 3 (R3) 1009.17 999.83 1006.88
Resistance 2 (R2) 999.83 993.91 1000.63 1005.58
Resistance 1 (R1) 993.67 990.25 996.75 995.25 1004.29
Pivot Point 984.33 984.33 985.88 985.13 984.33
Support 1 (S1) 978.17 978.41 981.25 979.75 970.71
Support 2 (S2) 968.83 974.75 969.63 969.42
Support 3 (S3) 962.67 968.83 968.13
Support 4 (S4) 964.25